Cargando…

Alterations of metabolic activity in human osteoarthritic osteoblasts by lipid peroxidation end product 4-hydroxynonenal

4-Hydroxynonenal (HNE), a lipid peroxidation end product, is produced abundantly in osteoarthritic (OA) articular tissues, but its role in bone metabolism is ill-defined. In this study, we tested the hypothesis that alterations in OA osteoblast metabolism are attributed, in part, to increased levels...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Qin, Vaillancourt, France, Côté, Véronique, Fahmi, Hassan, Lavigne, Patrick, Afif, Hassan, Di Battista, John A, Fernandes, Julio C, Benderdour, Mohamed
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1794501/
https://www.ncbi.nlm.nih.gov/pubmed/17042956
http://dx.doi.org/10.1186/ar2066
_version_ 1782132193874673664
author Shi, Qin
Vaillancourt, France
Côté, Véronique
Fahmi, Hassan
Lavigne, Patrick
Afif, Hassan
Di Battista, John A
Fernandes, Julio C
Benderdour, Mohamed
author_facet Shi, Qin
Vaillancourt, France
Côté, Véronique
Fahmi, Hassan
Lavigne, Patrick
Afif, Hassan
Di Battista, John A
Fernandes, Julio C
Benderdour, Mohamed
author_sort Shi, Qin
collection PubMed
description 4-Hydroxynonenal (HNE), a lipid peroxidation end product, is produced abundantly in osteoarthritic (OA) articular tissues, but its role in bone metabolism is ill-defined. In this study, we tested the hypothesis that alterations in OA osteoblast metabolism are attributed, in part, to increased levels of HNE. Our data showed that HNE/protein adduct levels were higher in OA osteoblasts compared to normal and when OA osteoblasts were treated with H(2)O(2). Investigating osteoblast markers, we found that HNE increased osteocalcin and type I collagen synthesis but inhibited alkaline phosphatase activity. We next examined the effects of HNE on the signaling pathways controlling cyclooxygenase-2 (COX-2) and interleukin-6 (IL-6) expression in view of their putative role in OA pathophysiology. HNE dose-dependently decreased basal and tumour necrosis factor-α (TNF-α)-induced IL-6 expression while inducing COX-2 expression and prostaglandin E(2 )(PGE(2)) release. In a similar pattern, HNE induces changes in osteoblast markers as well as PGE(2 )and IL-6 release in normal osteoblasts. Upon examination of signaling pathways involved in PGE(2 )and IL-6 production, we found that HNE-induced PGE(2 )release was abrogated by SB202190, a p38 mitogen-activated protein kinase (MAPK) inhibitor. Overexpression of p38 MAPK enhanced HNE-induced PGE(2 )release. In this connection, HNE markedly increased the phosphorylation of p38 MAPK, JNK2, and transcription factors (CREB-1, ATF-2) with a concomitant increase in the DNA-binding activity of CRE/ATF. Transfection experiments with a human COX-2 promoter construct revealed that the CRE element (-58/-53 bp) was essential for HNE-induced COX-2 promoter activity. However, HNE inhibited the phosphorylation of IκBα and subsequently the DNA-binding activity of nuclear factor-κB. Overexpression of IKKα increased TNF-α-induced IL-6 production. This induction was inhibited when TNF-α was combined with HNE. These findings suggest that HNE may exert multiple effects on human OA osteoblasts by selective activation of signal transduction pathways and alteration of osteoblastic phenotype expression and pro-inflammatory mediator production.
format Text
id pubmed-1794501
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-17945012007-02-08 Alterations of metabolic activity in human osteoarthritic osteoblasts by lipid peroxidation end product 4-hydroxynonenal Shi, Qin Vaillancourt, France Côté, Véronique Fahmi, Hassan Lavigne, Patrick Afif, Hassan Di Battista, John A Fernandes, Julio C Benderdour, Mohamed Arthritis Res Ther Research Article 4-Hydroxynonenal (HNE), a lipid peroxidation end product, is produced abundantly in osteoarthritic (OA) articular tissues, but its role in bone metabolism is ill-defined. In this study, we tested the hypothesis that alterations in OA osteoblast metabolism are attributed, in part, to increased levels of HNE. Our data showed that HNE/protein adduct levels were higher in OA osteoblasts compared to normal and when OA osteoblasts were treated with H(2)O(2). Investigating osteoblast markers, we found that HNE increased osteocalcin and type I collagen synthesis but inhibited alkaline phosphatase activity. We next examined the effects of HNE on the signaling pathways controlling cyclooxygenase-2 (COX-2) and interleukin-6 (IL-6) expression in view of their putative role in OA pathophysiology. HNE dose-dependently decreased basal and tumour necrosis factor-α (TNF-α)-induced IL-6 expression while inducing COX-2 expression and prostaglandin E(2 )(PGE(2)) release. In a similar pattern, HNE induces changes in osteoblast markers as well as PGE(2 )and IL-6 release in normal osteoblasts. Upon examination of signaling pathways involved in PGE(2 )and IL-6 production, we found that HNE-induced PGE(2 )release was abrogated by SB202190, a p38 mitogen-activated protein kinase (MAPK) inhibitor. Overexpression of p38 MAPK enhanced HNE-induced PGE(2 )release. In this connection, HNE markedly increased the phosphorylation of p38 MAPK, JNK2, and transcription factors (CREB-1, ATF-2) with a concomitant increase in the DNA-binding activity of CRE/ATF. Transfection experiments with a human COX-2 promoter construct revealed that the CRE element (-58/-53 bp) was essential for HNE-induced COX-2 promoter activity. However, HNE inhibited the phosphorylation of IκBα and subsequently the DNA-binding activity of nuclear factor-κB. Overexpression of IKKα increased TNF-α-induced IL-6 production. This induction was inhibited when TNF-α was combined with HNE. These findings suggest that HNE may exert multiple effects on human OA osteoblasts by selective activation of signal transduction pathways and alteration of osteoblastic phenotype expression and pro-inflammatory mediator production. BioMed Central 2006 2006-10-16 /pmc/articles/PMC1794501/ /pubmed/17042956 http://dx.doi.org/10.1186/ar2066 Text en Copyright © 2006 Shi et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Shi, Qin
Vaillancourt, France
Côté, Véronique
Fahmi, Hassan
Lavigne, Patrick
Afif, Hassan
Di Battista, John A
Fernandes, Julio C
Benderdour, Mohamed
Alterations of metabolic activity in human osteoarthritic osteoblasts by lipid peroxidation end product 4-hydroxynonenal
title Alterations of metabolic activity in human osteoarthritic osteoblasts by lipid peroxidation end product 4-hydroxynonenal
title_full Alterations of metabolic activity in human osteoarthritic osteoblasts by lipid peroxidation end product 4-hydroxynonenal
title_fullStr Alterations of metabolic activity in human osteoarthritic osteoblasts by lipid peroxidation end product 4-hydroxynonenal
title_full_unstemmed Alterations of metabolic activity in human osteoarthritic osteoblasts by lipid peroxidation end product 4-hydroxynonenal
title_short Alterations of metabolic activity in human osteoarthritic osteoblasts by lipid peroxidation end product 4-hydroxynonenal
title_sort alterations of metabolic activity in human osteoarthritic osteoblasts by lipid peroxidation end product 4-hydroxynonenal
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1794501/
https://www.ncbi.nlm.nih.gov/pubmed/17042956
http://dx.doi.org/10.1186/ar2066
work_keys_str_mv AT shiqin alterationsofmetabolicactivityinhumanosteoarthriticosteoblastsbylipidperoxidationendproduct4hydroxynonenal
AT vaillancourtfrance alterationsofmetabolicactivityinhumanosteoarthriticosteoblastsbylipidperoxidationendproduct4hydroxynonenal
AT coteveronique alterationsofmetabolicactivityinhumanosteoarthriticosteoblastsbylipidperoxidationendproduct4hydroxynonenal
AT fahmihassan alterationsofmetabolicactivityinhumanosteoarthriticosteoblastsbylipidperoxidationendproduct4hydroxynonenal
AT lavignepatrick alterationsofmetabolicactivityinhumanosteoarthriticosteoblastsbylipidperoxidationendproduct4hydroxynonenal
AT afifhassan alterationsofmetabolicactivityinhumanosteoarthriticosteoblastsbylipidperoxidationendproduct4hydroxynonenal
AT dibattistajohna alterationsofmetabolicactivityinhumanosteoarthriticosteoblastsbylipidperoxidationendproduct4hydroxynonenal
AT fernandesjulioc alterationsofmetabolicactivityinhumanosteoarthriticosteoblastsbylipidperoxidationendproduct4hydroxynonenal
AT benderdourmohamed alterationsofmetabolicactivityinhumanosteoarthriticosteoblastsbylipidperoxidationendproduct4hydroxynonenal